Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 1/20 | 0.31 |
| ▸ | CTSC | P53634 | 1/20 | 0.30 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18116800 | 0.80 | TERT (0.36) | TERTCTSCPSMB5 | |
| SCHEMBL16620266 | 0.79 | DPP4 (0.39) | TERT | |
| SCHEMBL19331517 | 0.79 | TERT (0.40) | TERTPSMB5 | |
| SCHEMBL19331515 | 0.79 | TERT (0.40) | TERTPSMB5 | |
| SCHEMBL4087867 | 0.78 | TERT (0.32) | TERTCTSCPSMB5 | |
| SCHEMBL4092811 | 0.78 | CTSC (0.32) | CTSC | |
| SCHEMBL30869183 | 0.72 | METAP1 (0.38) | TERTCTSC | |
| SCHEMBL29421862 | 0.72 | NPSR1 (0.39) | — | |
| SCHEMBL31461744 | 0.71 | ECE1 (0.48) | CTSC | |
| SCHEMBL4087334 | 0.71 | CTSC (0.33) | CTSC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8076285-B2 | Lysobactin amides | AICURIS GMBH & CO. KG (DE) | 2011-12-13 | — | — | US | disclosed |
| US-20090203582-A1 | LYSOBACTIN AMIDES | BAYER HEALTHCARE AG (DE) | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203582-A1 | LYSOBACTIN AMIDES | AADAT, HAMP, DLST | TERT 3633/4885CTSC 619/4885PSMB5 2523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.